PHARMACOKINETICS OF MITOMYCIN-C IN RABBIT AND HUMAN

被引：35

作者：

VANHAZEL, GA ^{[1
]}

KOVACH, JS ^{[1
]}

机构：

[1] MAYO CLIN & MAYO FDN, DIV DEV ONCOL, ROCHESTER, MN 55905 USA

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 8卷 / 02期

关键词：

D O I：

10.1007/BF00255482

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：189 / 192

页数：4

共 19 条

[1]

BAKER L H, 1976, Medical and Pediatric Oncology, V2, P207, DOI 10.1002/mpo.2950020211

[2]

BAKER LH, 1979, MITOMYCIN C CURRENT, P77

[3]

FRANK W, 1960, CANCER CHEMOTH REP, P114

[4]

FUJITA H, 1971, JAP J CLIN ONCOL, V12, P151

[5]

GODFREY TE, 1972, CANCER, V29, P1647, DOI 10.1002/1097-0142(197206)29:6<1647::AID-CNCR2820290632>3.0.CO

[6]

2-6

[7] PHASE-II EVALUATION OF MITOMYCIN-C (MMC) IN CHILDREN WITH REFRACTORY SOLID TUMORS USING THE SINGLE HIGH-INTERMITTENT-DOSE SCHEDULE [J].

GUTIERREZ, ML ;

EVANS, A ;

ROHRBAUGH, T ;

BELASCO, J ;

LEE, FH ;

CROOKE, ST .

MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (04) :405-407

[8]

HATA T, 1961, CANCER CHEMOTH REP, P67

[9] ACTION DE LA MITOMYCINE C DANS 65 CAS DE TUMEURS MALIGNES . COMPARAISON DE LEFFET DE DOSES FAIBLES REPETEES + DE DOSES MASSIVES [J].

KENIS, Y ;

STRYCKMANS, P .

CHEMOTHERAPY, 1964, 8 (02) :114-&

[10]

KONITS PH, 1981, CANCER-AM CANCER SOC, V48, P1295, DOI 10.1002/1097-0142(19810915)48:6<1295::AID-CNCR2820480607>3.0.CO

← 1 2 →